Bio-Techne acquired by Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany agreed to acquire Bio-Techne, an United States / Germany life sciences brand, on Jun 25, 2026.
Preliminary: The announcement date is not yet independently verified.
Transaction summary
- Target
- Bio-Techne
- Acquirer
- Merck KGaA, Darmstadt, Germany
- Seller
- -
- Announced
- 2026-06-25(unverified)
- Geography
- United States / Germany
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-07-13
- Latest update
- 2026-10-29
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Enterprise value is unavailable.
Source summary
Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets - PR Newswire
ConfirmedPR Newswire item dated June 25, 2026 states that Merck KGaA, Darmstadt, Germany agreed to acquire Bio-Techne to strengthen its position in life sciences markets.
Open sourceContinue your research
Related transaction comps
Thermo Fisher Scientific’s microbiology business acquired by Astorg
2026-04-27 · Confirmed
View transaction → BiotechMyricx Bio acquired by Novartis
2026-07-06 · Confirmed
View transaction → BiotechXOMA acquired by Ligand
2026-04-27 · Confirmed
View transaction → BiotechCelgene acquired by Bristol-Myers Squibb
- · Confirmed
View transaction →